Analysis of websites containing takeda.us backlinks
These websites are/were linking to takeda.us.
Websites found: 21
Number of websited displayed: 21
List of results:
ENTYVIO® (vedolizumab) | Patient Informationhttp://site-overview.com/stats/entyvio.com
Prescription medicine option when other treatments haven't worked well enough or can't be tolerated.
- Google Analytics ID: 49842556-2
- Website Address renewal date: 17/3/31
- Domain Address Reg. date: 11/7/12
- Website address in use until: 18/7/12
Your Weight Matters - For Your Health!http://site-overview.com/stats/yourweightmatters.org
Talking about your weight is never easy, but the Your Weight Matters Campaign is here to help. We provide free resources for you!
- Google Analytics ID: 38788475-1
- Website Address renewal date: 17/2/21
- Domain Address Reg. date: 09/3/8
- Website address in use until: 19/3/8
ICLUSIG® (ponatinib)http://site-overview.com/stats/iclusig.com
- Google Analytics ID: 19850146-7
- Website Address renewal date: 17/7/17
- Domain Address Reg. date: 11/8/18
- Website address in use until: 19/8/18
AHAIC 2017 | Africa Health Agenda International Conferencehttp://site-overview.com/stats/ahaic.org
The Africa Health Agenda International Conference (AHAIC 2017) was held from March 7-9, 2017 at the Radisson Blu Hotel in Nairobi, Kenya. See you in 2019!
- Website Address renewal date: 17/4/21
- Domain Address Reg. date: 14/4/28
- Website address in use until: 19/4/28
Home | TRINTELLIX (vortioxetine)http://site-overview.com/stats/trintellix.com
TRINTELLIX (vortioxetine) is indicated for the treatment of major depressive disorder in adults. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a trend toward reduced risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. TRINTELLIX has not been evaluated for use in pediatric patients.
- Google Analytics ID: 35252106-2
- Website Address renewal date: 17/5/8
- Domain Address Reg. date: 14/7/10
- Website address in use until: 18/7/10
TRINTELLIX (vortioxetine) for U.S. Healthcare Professionalshttp://site-overview.com/stats/trintellixhcp.com
Find TRINTELLIX (vortioxetine) dosing information, clinical study results, safety data, clinical pharmacology and savings information. See Important Safety Information and Prescribing Information.
- Google Analytics ID: 91996158-1
- Website Address renewal date: 17/8/2
- Domain Address Reg. date: 15/9/4
- Website address in use until: 18/9/4
Global Community Bio Summithttp://site-overview.com/stats/biosummit.org
- Website Address renewal date: 17/8/1
- Domain Address Reg. date: 17/6/1
- Website address in use until: 18/6/1
DEXILANT (dexlansoprazole) for U.S. Healthcare Professionalshttp://site-overview.com/stats/dexilanthcp.com
Find DEXILANT (dexlansoprazole) dosing information, clinical data, safety data, and Instant Savings Card information. See Important Safety Information and Prescribing Information.
- Google Analytics ID: 29097032-1
- Website Address renewal date: 17/2/22
- Domain Address Reg. date: 11/6/29
- Website address in use until: 18/6/29
ULORIC (febuxostat) | Patient Informationhttp://site-overview.com/stats/uloric.com
- Google Analytics ID: 6912318-1
- Website Address renewal date: 17/2/22
- Domain Address Reg. date: 01/5/9
- Website address in use until: 18/5/9
Takeda Pharmaceuticals U.S.A., Inc.http://site-overview.com/stats/tap.com
- Website Address renewal date: 17/8/9
- Domain Address Reg. date: 94/4/5
- Website address in use until: 18/4/6
Takeda Pharmaceuticals U.S.A., Inc.http://site-overview.com/stats/takeda.us
- Website Address renewal date: 12/2/28
- Domain Address Reg. date: 08/9/18
- Website address in use until: 17/9/18
Breakthrough Greater Boston - Homehttp://site-overview.com/stats/breakthroughgreaterboston.org
Breakthrough Cambridge (BTC) is transforming urban education for students and teachers. Learn more about the breakthroughs that happen every day.
- Website Address renewal date: 15/3/17
- Domain Address Reg. date: 12/3/16
- Website address in use until: 18/3/16
Takeda MedConnect | Homehttp://site-overview.com/stats/takedamedconnect.com
Takeda MedConnect, operated by Takeda Medical Affairs, provides clinical information and resources about Takeda products to U.S. healthcare professionals.
- Google Analytics ID: 44186302-1
- Website Address renewal date: 17/8/9
- Domain Address Reg. date: 13/6/6
- Website address in use until: 18/6/6
Home | Healthcare professionals | Entyvio (vedolizumab)http://site-overview.com/stats/entyviohcp.com
Home | Information for healthcare professionals about Entyvio (vedolizumab), including indications, efficacy, and safety.
- Google Analytics ID: 48857948-2
- Website Address renewal date: 17/11/28
- Domain Address Reg. date: 13/11/27
- Website address in use until: 19/11/27
The NESINA Family - Learn About The Treatment Optionshttp://site-overview.com/stats/takedadiabetesadvantage.com
The NESINA Family are prescription medicines used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. Please see Important Safety Information, including boxed warnings.
- Google Analytics ID: 40710438-6
- Website Address renewal date: 17/8/31
- Domain Address Reg. date: 13/3/20
- Website address in use until: 18/3/20
Patient Information | ROZEREM (ramelteon)http://site-overview.com/stats/rozerem.com
ROZEREM (ramelteon) is approved for adults having trouble falling asleep from insomnia. Ask your doctor about ROZEREM. See Important Safety Information and Prescribing Information.
- Google Analytics ID: 5275299-2
- Website Address renewal date: 17/10/11
- Domain Address Reg. date: 05/2/25
- Website address in use until: 19/2/25
Vision2Voice - Leaders In Healthcare Communicationshttp://site-overview.com/stats/vision2voice.com
Vision2Voice brings deep, broad, and relevant medical education experience to help pharmaceutical companies connect their messaging and their vision to their audiences
- Google Analytics ID: 39335521-1
- Website Address renewal date: 16/6/24
- Domain Address Reg. date: 08/6/26
- Website address in use until: 19/6/26
Patient Information DEXILANT (dexlansoprazole)http://site-overview.com/stats/dexilant.com
Product information on treatment with DEXILANT (dexlansoprazole) and resources to help you understand and manage your condition. See full safety and prescribing information.
- Google Analytics ID: 5448303-4
- Website Address renewal date: 16/11/16
- Domain Address Reg. date: 10/2/10
- Website address in use until: 18/2/10